Ticker: RGLS

Company: Regulus Therapeutics Inc.

Person: Preston Klassen, director, officer

Transaction date: June 3, 2025

Reporting date: June 4, 2025

Average share price: 7.987700000000001

Bought 12000.0 shares for 95852.4